PM

Peter Meintjes

Chief Commercial Officer, Transplant Genomics at Eurofins

Dr. Meintjes joins TGI after six years at Omixon, world leader in pre-transplant HLA Typing, where he departs as CEO, having grown the company at a CAGR of >75% since its first full year of operation as a molecular diagnostics company.

Timeline

  • Chief Commercial Officer, Transplant Genomics

    Current role

View in org chart